IREZTradr 2X Short Iren Daily ETF
Seeks daily investment results of -200% of the daily performance of IREN Limited shares.
By AXS · Launched 2026
1.49%
#5,410 of 5,562 · expensive
$21M
#4,322 of 5,562 · small
N/A
5 months
#5,197 of 5,562 · young
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightAsset allocation
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsWorst peak-to-trough loss
Needs 3+ years of history
Needs 3+ years of history
Where to buy
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks daily investment results of -200% of the daily performance of IREN Limited shares.
- Strategy
- Invests primarily in financial instruments providing 2x inverse leveraged exposure to IREN. Designed for daily trading, the fund's performance may differ significantly over longer periods due to compounding effects.
- Inception date
- January 21, 2026
- Fund family
- AXS
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Leveraged single-stock ETF — documented structural drag
Single-stock leveraged ETFs magnify one stock's daily move. Research on these products (Bessembinder et al., 2024) finds 56% posted negative absolute returns over one year, with ~9.5% annual drag versus the underlying stock. Daily rebalancing plus financing costs work against the investor on any holding period longer than a few days.
Source: Bessembinder, Cooper, Zhang — 'Leveraged Single-Stock ETFs' (SSRN 2024)
Why we flagged this: strategy=inverse + single_stock_wrapper
Inverse ETF — daily tool only
Delivers the inverse of the benchmark's daily return. The compounding path makes multi-day holding unpredictable even when the benchmark's total move goes your way. Legitimate as a one-day hedge; dangerous as a view.
Source: Cheng & Madhavan (2009)
Why we flagged this: strategy=inverse + inverse_name_or_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed IREZ. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19